145 related articles for article (PubMed ID: 16421102)
1. The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway.
Moshnikova A; Frye J; Shay JW; Minna JD; Khokhlatchev AV
J Biol Chem; 2006 Mar; 281(12):8143-52. PubMed ID: 16421102
[TBL] [Abstract][Full Text] [Related]
2. Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation.
Bee C; Moshnikova A; Mellor CD; Molloy JE; Koryakina Y; Stieglitz B; Khokhlatchev A; Herrmann C
J Biol Chem; 2010 May; 285(21):16258-66. PubMed ID: 20339001
[TBL] [Abstract][Full Text] [Related]
3. NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
Calvisi DF; Donninger H; Vos MD; Birrer MJ; Gordon L; Leaner V; Clark GJ
Cancer Res; 2009 Jun; 69(11):4629-37. PubMed ID: 19435914
[TBL] [Abstract][Full Text] [Related]
4. Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.
Schmidt ML; Donninger H; Clark GJ
J Biol Chem; 2014 Nov; 289(45):31102-10. PubMed ID: 25217643
[TBL] [Abstract][Full Text] [Related]
5. Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases.
Aoyama Y; Avruch J; Zhang XF
Oncogene; 2004 Apr; 23(19):3426-33. PubMed ID: 15007383
[TBL] [Abstract][Full Text] [Related]
6. Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases.
Avruch J; Praskova M; Ortiz-Vega S; Liu M; Zhang XF
Methods Enzymol; 2006; 407():290-310. PubMed ID: 16757333
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the growth and tumour suppressor NORE1A with microtubules is not required for its growth-suppressive function.
Moshnikova A; Kuznetsov S; Khokhlatchev AV
BMC Res Notes; 2008 May; 1():13. PubMed ID: 18710533
[TBL] [Abstract][Full Text] [Related]
8. Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma.
Shinmura K; Tao H; Nagura K; Goto M; Matsuura S; Mochizuki T; Suzuki K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
Lung Cancer; 2011 Jan; 71(1):19-27. PubMed ID: 20434789
[TBL] [Abstract][Full Text] [Related]
9. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
Barnoud T; Schmidt ML; Donninger H; Clark GJ
Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
[TBL] [Abstract][Full Text] [Related]
10. Ras Regulates Rb via NORE1A.
Barnoud T; Donninger H; Clark GJ
J Biol Chem; 2016 Feb; 291(6):3114-23. PubMed ID: 26677227
[TBL] [Abstract][Full Text] [Related]
11. Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.
Stieglitz B; Bee C; Schwarz D; Yildiz O; Moshnikova A; Khokhlatchev A; Herrmann C
EMBO J; 2008 Jul; 27(14):1995-2005. PubMed ID: 18596699
[TBL] [Abstract][Full Text] [Related]
12. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
Donninger H; Calvisi DF; Barnoud T; Clark J; Schmidt ML; Vos MD; Clark GJ
J Cell Biol; 2015 Mar; 208(6):777-89. PubMed ID: 25778922
[TBL] [Abstract][Full Text] [Related]
13. The growth and tumor suppressors NORE1A and RASSF1A are targets for calpain-mediated proteolysis.
Kuznetsov S; Khokhlatchev AV
PLoS One; 2008; 3(12):e3997. PubMed ID: 19098985
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.
Elowe S; Holland SJ; Kulkarni S; Pawson T
Mol Cell Biol; 2001 Nov; 21(21):7429-41. PubMed ID: 11585923
[TBL] [Abstract][Full Text] [Related]
15. [Influence of phosphoprotein associated with glycosphingolipid microdomains 1 on biologic behavior of human prostatic cancer cell line in-vitro].
Yu WJ; Wang YW; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):615-20. PubMed ID: 21092590
[TBL] [Abstract][Full Text] [Related]
16. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.
Geli J; Kogner P; Lanner F; Natalishvili N; Juhlin C; Kiss N; Clark GJ; Ekström TJ; Farnebo F; Larsson C
Int J Cancer; 2008 Jul; 123(2):389-394. PubMed ID: 18452173
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
18. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.
Yaari S; Jacob-Hirsch J; Amariglio N; Haklai R; Rechavi G; Kloog Y
Clin Cancer Res; 2005 Jun; 11(12):4321-30. PubMed ID: 15958613
[TBL] [Abstract][Full Text] [Related]
19. NORE1A induction by membrane-bound CD40L (mCD40L) contributes to CD40L-induced cell death and G1 growth arrest in p21-mediated mechanism.
Elmetwali T; Salman A; Palmer DH
Cell Death Dis; 2016 Mar; 7(3):e2146. PubMed ID: 26986513
[TBL] [Abstract][Full Text] [Related]
20. Cdc42 and Ras cooperate to mediate cellular transformation by intersectin-L.
Wang JB; Wu WJ; Cerione RA
J Biol Chem; 2005 Jun; 280(24):22883-91. PubMed ID: 15824104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
